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Summary
Benign adult familial myoclonic epilepsy is an autosomal
dominant idiopathic epileptic syndrome characterizedby
adult-onset tremulous finger movement, myoclonus, ep-
ileptic seizures, and nonprogressive course. It was re-
cently recognized in Japanese families. In this study, we
report that the gene locus is assigned to the distal long
arm of chromosome 8, by linkage analysis in a large
Japanese kindred with a maximum two-point LOD score
of 4.31 for D8S555 at recombination fraction of 0 (max-
imum multipoint LOD score of 5.42 for the interval
between D8S555 and D8S1779). Analyses of recombi-
nations place the locus within an 8-cM interval, between
D8S1784 and D8S1694, in which three markers,
D8S1830, D8S555, and D8S1779, show no recombi-
nation with the phenotypes. Although three other epi-
lepsy-related loci on chromosome 8q have been recog-
nized—one on chromosome 8q13-21 (familial febrile
convulsion) and two others on chromosome 8q24
(KCNQ3 and childhood absence epilepsy)—the locus
assigned here is distinct from these three epilepsy-related
loci. This study establishes the presence of a new epi-
lepsy-related locus on 8q23.3-q24.11.
Introduction
Epilepsy is characterized by recurrent, transient distur-
bances of neuronal synchrony and is one of the most
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common medical conditions, affecting ∼4% of individ-
uals at some time in their lives (Hauser et al. 1993).
Twin studies have demonstrated a substantial genetic
influence in epilepsy, among the common medical dis-
orders (Plomin et al. 1994). To identify the pathogenic
mechanisms underlying epilepsies, it is important tomap
and clone the genes responsible for epileptic syndromes
with a Mendelian mode of inheritance, and to define
their mutations.
Inazuki et al. (1990) pointed out the presence of au-
tosomal dominant Japanese familial cases of epilepsy
with adult onset–type myoclonus (40 patients from 12
families) and a benign course, without reporting specific
neuropathological findings. Ikeda et al. (1990) reported
electrophysiological studies in two Japanese patients
who had adult-onset finger tremor, seizure, and family
history of the same condition without a progressive
course. They demonstrated involuntary movement as a
form of cortical reflex myoclonus. Yasuda (1991) re-
ported in detail electrophysiological studies in two sim-
ilar large Japanese families. He proposed the syndrome
of benign adult familial myoclonic epilepsy (BAFME;
MIM 601068).
The clinical features of BAFME are (1) autosomal
dominant inheritance, tremulous finger movement, and/
or myoclonus of the extremities after adolescence; (2)
infrequent epileptic seizure; (3) abnormality of poly-
spikes and waves on examination by electroencephalo-
gram (EEG) and marked photosensitivity; (4) enlarged
cortical components of somatosensory-evokedpotential;
(5) enhanced long-loop reflex (C-reflex); (6) positive
spikes preceding myoclonus, ascertained with the jerk-
locked–averaging method; and (7) benign nonprogres-
sive course without cerebellar ataxia and dementia. To
date, similar familial cases have been reported only from
Japan (Okino 1997; Terada et al. 1997). Hashimoto et
al. (1993) reported the possible linkage between familial
myoclonus epilepsy and human leukocyte antigen–B
phenotype, which was reported as a genetic marker
linked to juvenile myoclonus epilepsy. Kuwano et al.
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(1996) investigated CAG repeats in the dentatorubral
pallidoluysian atrophy (DRPLA) gene and found no ab-
normal CAG expansion in the subjects affected with
BAFME. Their linkage analysis using DNA polymor-
phisms in the DRPLA gene excluded it as a site for the
mutation for BAFME.
Recently, significant progress has been made in the
mapping and isolation of genes for epilepsy syndrome.
Idiopathic single-gene generalized epilepsies include two
types of benign familial neonatal convulsions (BFNC),
for which loci have been identified: one that maps to
20q (BFNC1) and was shown to result from mutations
in a voltage-gated potassium-channel gene, KCNQ2
(Singh et al. 1998); and a second that maps to 8q24
(BFNC2) and was demonstrated to be caused by mu-
tations in another voltage-gated potassium-channel
gene, KCNQ3 (Charlier et al. 1998). Benign familial
infantile convulsions is an autosomal dominant disorder
whose gene was mapped to chromosome 19 by linkage
analysis (Guipponi et al. 1997). Scheffer and Berkovic
(1997) described a clinical subset, termed “generalized
epilepsy with febrile seizures plus” (GEFS). Wallace et
al. (1998) found linkage to 19q13.1 in a large GEFS
family and identified a mutation in the voltage-gated
sodium channel b1 subunit gene (SCN1B). Other loci
for febrile seizures reported are chromosomes 8q13-21
(Wallace et al. 1996) and 19p (Johnson et al. 1998).
Fong et al. (1998) reported the linkage of childhood-
absence epilepsy to chromosome 8q24. Recently, auto-
somal dominant inheritance in idiopathic partial epilep-
sies has also been described. In autosomal dominant noc-
turnal frontal lobe epilepsy (ADNFLE), a defect in the
gene of the a4 subunit of the nicotinic-acetylcholine re-
ceptor located on 20q13.2 was found (Phillips et al.
1995), which was the first genetic defect described in an
idiopathic epilepsy. Neubauer et al. (1998) found evi-
dence for linkage of benign epilepsy of childhood with
centrotemporal spikes, or rolandic epilepsy, to a region
on chromosome 15q14. The chromosomal area, 15q14,
has been reported to be linked to the phenotype in fam-
ilies with an auditory-neurophysiologic deficit, as well
as in families with juvenile myoclonic epilepsy (Elmslie
et al. 1997). In familial temporal lobe epilepsy, linkage
to chromosome 10q has been reported (Ottman et al.
1995). In this report, we report evidence that a new




Linkage analysis was performed in a large Japanese
family, partly described elsewhere (fig. 1). Altogether, 27
individuals, including 17 affected patients, were studied.
From each consenting individual, 10 ml venous blood
was collected and used to extract high-molecular-weight
DNA.
Following is a brief summary of the clinical features
associated with BAFME. Patients developed normally up
to adolescence. The onset of symptoms is tremulous fin-
ger movement and/or myoclonus of the extremities at
an average age of 30.5 years (range 18–45 years). The
tremulous finger movements were classified electrophy-
siolosically into two types: one with a relatively stable
frequency of ∼9–10 Hz, and one with a more variable
frequency. There is a variation of symptoms. For in-
stance, myoclonus was limited in the upper extremities
in half of the patients, but in the other half myoclonus
appeared in both upper and lower extremities. Gener-
alized tonic-clonic convulsions occurred infrequently, of-
ten fewer than four times throughout the life span. Ep-
ileptic seizures have not yet been observed in two
patients (patient II-23 and patient III-7). None of the
patients developed either cerebellar ataxia or dementia
during the observation period of 110 years. EEGs were
abnormal in all patients, and generalized polyspikes and
wave complexes were observed in most patients. Pho-
toparoxysmal responses were evoked, and photomy-
oclonus was induced by photic stimulation in some pa-
tients. In the sensory-evoked potentials (SEP) study, the
amplitude of the components of SEP (P25 and N33) was
increased in all patients. The amplitude of the N75,
P100, and/or N145 components was increased by photic
stimulation in all seven examined patients in whom vi-
sual-evoked potentials were recorded. By use of the jerk-
locked–averaging method, with myoclonus of upper ex-
tremity as a trigger, positive spikes preceding myoclonus
were observed in four patients. A C-reflex was recorded
in all patients. Cranial computed tomography showed
no particular abnormal findings except mild cerebral-
cortex atrophy in three patients. The serum levels of
lactate and pyruvate were within the normal range. For
treatment, valproate and clonazepam were effective for
both myoclonus and epilepsy.
Microsatellite-Marker Analysis
Highly polymorphic microsatellite markers were se-
lected from the Ge´ne´thon human genetic linkage map
(Ge´ne´thon; Dib et al. 1996). The primer sequences are
from the Genome Database. Other trinucleotide-repeat
polymorphisms related to neurodegenerative disorders
were analyzed. PCR amplification was performed on 50
ng genomic DNA with 32P-dCTP. PCR conditions were
30 cycles of 94C for 1 min, specific annealing temper-
ature for each primer for 1 min, and 72C for 1 min.
PCR products were separated onto 6% denaturating
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Figure 1 Pedigree of a large Japanese family with BAFME. Blackened symbols indicate the affected subjects, and unblackened
symbols indicate those with no signs or symptoms. A question mark (?) indicates a subject who has not been examined completely. The
alleles of the 18 markers are shown under each individual, in the order indicated to the left.
polyacrylamide gels and were visualized by fluorography
with the BAS1000 system (FujiFilm).
LOD-Score Linkage Analysis
Two-point linkage LOD-score analysis was performed
with use of MLINK from the LINKAGE software pack-
age version 5.1 (Lathrop et al. 1984). Marker-allele fre-
quencies were derived from 50 Japanese control subjects.
The frequency for the disease allele was estimated at
∼.00001. LOD scores were calculated at recombination
fractions (v) of .00, .10, .20, .30, .40, and .50. We used
an autosomal dominant model with 100% penetrance,
assuming the frequency of the affected allele to be
0.00001. Multipoint linkage analysis was performed
with the program LINKMAP, using 2 of 16 informative
markers each time, from centromere to telomere.Marker
order and recombination fractions were obtained from
Ge´ne´thon (Dib et al. 1996).
Results
As an initial step, we studied whether BAFME is a
variant form of DRPLA, which is a frequent cause of
myoclonic epilepsy in the Japanese. The patients with
BAFME possess no abnormal expansion of the CAG-
tandem repeat in the DRPLA gene and the linkage anal-
ysis using the triplet-repeat polymorphism excluded the
DRPLA gene as a site for the BAFME mutation (we
obtained a two-point LOD score of8 at ), whichv = .00
confirm the results obtained by Kuwano et al. (1996).
Other trinucleotide-repeat polymorphisms that have
been reported to be associated with neurodegenerative
diseases were studied. None of them, however, showed
abnormal expansion, and negative LOD scores were also
obtained. Next, 120 dinucleotide microsatellitemarkers,
including the ones that lie in regions corresponding to
previously mapped epilepsies (6p and 21q22.3), were
genotyped before linkage was detected (Greenberg et al.
1987; Lehesjoki et al. 1993). Two-point maximum-like-
lihood calculations were performed after complete ge-
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Table 1
Pairwise LOD Scores for BAFME Versus Chromosome 8q Markers
MARKER
LOD SCORE AT v =
vmax
a Zmax
b.0000 .0050 .0100 .0200 .0300 .04000
D8S530  2.738 1.233 .0064 .0292 .0268 .0340 .0318
D8S1834 1.078 2.110 2.035 1.583 1.030 .0484 .0055 2.298
D8S556 1.961 1.725 1.499 1.083 .0708 .0352 .0000 1.961
D8S1703 1.631 1.586 1.536 1.166 .0715 .0262 .0061 1.594
D8S1784 1.660 1.446 1.315 .0739 .0067 .0297 .0051 1.446
D8S1830 2.092 1.830 1.573 1.085 .0639 .0250 .0000 2.092
D8S555 4.108 3.710 3.295 2.411 1.468 .0556 .0000 4.108
D8S1779 4.314 3.928 3.530 2.688 1.784 .0838 .0000 4.314
D8S1694 3.437 .0933 .0923 .0617 .0276 .0045 .0070 .0955
D8S1802 1.858 1.672 1.487 1.114 .0734 .0353 .0000 1.858
D8S514 2.330 1.383 1.340 .0963 .0542 .0206 .0063 1.395
D8S1804  1.096 1.342 1.194 .0776 .0338 .0118 1.355
D8S1832  .0025 .0580 .0767 .0519 .0206 .0174 .0782
D8S1799 2.848 2.309 2.003 1.602 1.055 .0490 .0065 2.053
D8S266  1.308 1.619 1.522 1.089 .0539 .0129 1.651
D8S1774  1.102 .0036 .0775 .0833 .0552 .0261 .0860
D8S284  .0718 .0108 .0208 .0180 .0074 .0229 .0218
D8S1837  .0715 .0129 .0660 .0682 .0422 .0255 .0714
a Maximum v.
b Maximum LOD score.
Figure 2 Multipoint LOD scores for genetic location on
chromosome 8q. Genetic distances from D8S530 are in centimor-
gans. The telomere is to the right. Arrows indicate the markers
that provide each LOD score.
notyping with one marker. We detected preliminary ev-
idence for linkage with D8S284 (we obtained a
maximum two-point LOD score of 0.214 at ),v = .25
which was associated with BFNC2. This prompted us
to study additional markers on chromosome 8q. On the
basis of the positions reported, 17 other markers on
chromosome 8q were studied. The results of two-point
LOD scores between the disease phenotype and each
marker loci and haplotype analysis for these markers are
shown in table 1 and figure 1, respectively.
The maximum LOD score obtained was 4.314 at
at D8S1779 in a two-point analysis. For D8S555v = .00
and D8S1830, no recombinations were observed (v =
), with maximum LOD scores of 4.108 and 2.092,.00
respectively. Results of the three-point analysis confirm
linkage between the disease phenotype and this region,
since a maximum multipoint LOD score of 5.42 for the
interval between D8S555 and D8S1779 was observed
(fig. 2). The proximal recombination site is between
D8S1784 and D8S1830, as observed in six affected
members comprising patient I-2’s offspring (patients II-
4, II-5, II-7, III-3, III-4, and III-7), and the distal site is
between D8S1779 and D8S1694, which occurred in an
affected family member (patient II-18). These
results suggest the susceptibility area of this disease to
be within the 8-cM interval between D8S1784 and
D8S1694.
Discussion
After examining 120 microsatellite markers lying in
the regions corresponding to the previously mapped loci
for epilepsies and excluding them as a site for mutation,
we obtained strong evidence for the localization of a
gene for BAFME, which maps to chromosome 8q23.3-
24.11, with a maximum multipoint LOD score of 5.42
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Figure 3 Genetic map of chromosome 8q region near
BAFME, on the basis of the CEPH/Ge´ne´thon chromosome 8 link-
age map (Ge´ne´thon). Relative positions of the BAFME locus and
of the other three loci for epilepsy-related syndromes, familial feb-
rile convulsions, BFNC2, and CAE are indicated.
for the interval between D8S555 and D8S1779. Three
other epilepsy syndromes have been mapped to chro-
mosome 8q. The gene locus for familial febrile convul-
sions was mapped to the region flanked by markers
D8S553 and D8S279 (chromosome 8q13-21; Wallace et
al. 1996), and this region is ∼30 cM centromeric to our
BAFME locus. Lewis et al. (1993) reported the linkage
of BFNC2 to markers D8S284 and D8S256, localized
on chromosome 8q24.13-qtel, and the same region was
implicated in families with an idiopathic generalized ep-
ilepsy syndrome (Zara et al. 1995). Our BAFME locus
is 23 cM centromeric from D8S284, with which we ob-
tained a maximum two-point LOD score of 0.214 at
. The locus for childhood absence epilepsyv = 0.25
(CAE) was mapped to 8q24 (Fong et al. 1998), further
telomeric, by several centimorgans, from D8S256. Pre-
sent results, together with the above reports, indicate
that the locus for BAFME assigned here is distinct from
other loci for epilepsy syndromes mapped to chromo-
some 8q (fig. 3).
We cannot estimate the proportion of BAFME that
can be attributed to alleles at this locus, since our anal-
ysis was restricted to a single family. Study of additional
families is required to further investigation of the effects
of the allele and locus heterogeneity. It is interesting that
BAFME and similar cases have been reported only from
Japan, as far as we know, which indicates the possibility
of the existence of a founder effect in this disorder.
Recent progress in molecular genetics in epilepsy has
shed light on the understanding of the basic mechanisms
of epileptogenesis. A mutation in the gene CHRNA4,
encoding the a4 subunit of the ionotropic-type neuronal
nicotinic-acetylcholine receptor (nAChR) was recently
identified in ADNFLE (Steinlein et al. 1995). In vitro
studies have demonstrated that the mutation results in
reduced permeability to calcium (Kuryatov et al. 1997;
Bertrand et al. 1998). The gene for BAFME may be a
gene for a type of nAChR subunit, and human genes
encoding the a2 and b3 subunits of the nAChR
(CHRNA2 and CHRNB3) have been mapped to chro-
mosome 8. However, the precise location of both genes
recently has been found to be chromosome 8p (Koyama
et al. 1994; Wood et al. 1995). The glutamate-binding
subunit of another ionotropic receptor, the NMDA re-
ceptor (GRINA), was mapped to 8q24.3 (Lewis et al.
1996), which is distal to the region defined for BAFME.
Causative mutations in KCNQ2 and KCNQ3 in BFNC1
and BFNC2, and a sodium-channel gene (SCN1B) in
febrile seizures and generalized epilepsies, have been
demonstrated (Biervert et al. 1998; Charlier et al. 1998;
Singh et al. 1998; Wallace et al. 1998). Although these
genes locate differently from the loci for BAFME, as
mentioned above, these findings may suggest a gene
search for other ion channels or ion channel–related
molecules as the candidate. Finally, we would like to
emphasize that BAFME is a novel entity, as shown by
its clinical picture and the distinct locus assigned here.
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